Immune response following miltefosine therapy in a patient with post-kala-azar dermal leishmaniasis
- PMID: 18639311
- DOI: 10.1016/j.trstmh.2008.05.015
Immune response following miltefosine therapy in a patient with post-kala-azar dermal leishmaniasis
Abstract
We report a case of post-kala-azar dermal leishmaniasis in which real-time PCR was exploited to measure changes in cytokine transcripts in lesion tissue before and after oral miltefosine treatment. Unlike antimonial therapy elevated levels of IFNgamma transcripts were noted, whereas TNFalpha, IL-10 and transforming growth factor-beta declined similar to that observed after therapy with antimonials. A significant increase in IFNgamma and CD40 levels seen after miltefosine therapy could enhance parasite clearance. The patient remained normal after 18 months of follow-up.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
